Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement-Reference-Cited by-同舟云学术

Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement

Published:2014-04-02 Issue:8 Volume:98 Page:1023-1027
ISSN:0007-1161
Container-title:British Journal of Ophthalmology
language:en
Short-container-title:Br J Ophthalmol

Author:

Fukushima Atsuki,Ohashi Yuichi,Ebihara Nobuyuki,Uchio Eiichi,Okamoto Shigeki,Kumagai Naoki,Shoji Jun,Takamura Etsuko,Nakagawa Yayoi,Namba Kenichi,Fujishima Hiroshi,Miyazaki Dai

Publisher

BMJ

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference22 articles.

1. Allergy and the eye;Leonardi;Clin Exp Immunol,2008

2. Ocular complications of vernal keratoconjuctivitis;Tabbara;Can J Ophthalmol,1999

3. Japanese guideline for allergic conjunctival diseases;Takamura;Allergol Int,2011

4. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis;Ohashi;J Ocul Pharmacol Ther,2010

5. Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis;Ang;Clin Ophthalmol,2012

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the complexity – Insights and interventions of refractory vernal keratoconjunctivitis;The Ocular Surface;2024-10

2. Alleviation of allergic rhinoconjunctivitis symptoms in participants treated with a 0.005% tacrolimus eye drop solution;2024-05-01

3. Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators;Life;2024-03-09

4. Long-Term Clinical Outcome of Tacrolimus Skin Ointment (0.03%) for the Treatment of Vernal Keratoconjunctivitis: A Quasi-Experimental Study;Cureus;2023-12-15

5. Tacrolimus-Loaded Cationic Nanoemulsion In-Situ Gel System: In-Vitro Characterization and Performance in a Dry-Eye Rabbit Model;Journal of Pharmaceutical Sciences;2023-11